心血管疾病流行病学研究.pptVIP

EZT 2005-W-166238-SS Epidemiology of Cardiovascular Disease Major Types of Cardiovascular Disease (CVD) Deaths Due to CHD and Stroke in Europe Deaths Due to CVD vs Other Diseases in Europe Cardiovascular Mortality Increases Sharply With Serum Cholesterol Concentration in Patients With Diabetes IHD Mortality: Less Substantial Decline in Diabetes Patients Vs Nondiabetic Subjects Major Modifiable Risk Factors for CVD The Gap Between CHD Prevention Guidelines and Practice Statin therapy effectively reduces the risk of mortality and major coronary events in individuals with hypercholesterolemia or hyperlipidemic patients with or without CHD. Nevertheless, there is a wide gap between target LDL-C levels established by treatment guidelines and those achieved in clinical practice. Only 15.5% of German Physicians Reported Knowledge of ESC Guidelines for CHD Prevention Only 15% of European Primary Care Physicians Surveyed Adhered to Current European CVD Prevention Guidelines EUROASPIRE II: Almost 40% of At-Risk Patients With Hyperlipidemia Did Not Receive Dietary Advice EUROASPIRE II: Almost 40% of At-Risk Patients With Hyperlipidemia Did Not Receive Lipid-Lowering Therapy EUROASPIRE II: Only 51% of Patients on Lipid-Lowering Therapy Achieved Total Cholesterol Goala Summary CVD (primarily CHD and stroke) is the most common cause of mortality in Europe. Although dyslipidemia is a modifiable risk factor, studies in Europe showed A Knowledge Gap A minority of German physicians surveyed reported knowledge of ESC guidelines An Action Gap A minority of European physicians surveyed were treating patients according to ESC guidelines A Treatment Gap Only half of at-risk patients were achieving total cholesterol goals Less than half of hyperlipidemic patients were achieving LDL-C goals Bibliography Please see notes page. Epidemiology of Cardiovascular Disease * Slide * Slide * Adapted from Mackay J, Mensah G, eds. The Atlas of Heart Disease and Stroke. The WHO and the US C